Skip to main content

The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro

International Urology and Nephrology volume 51, pages 1883–1892 (2019)Cite this article

Abstract

Background

Diabetic nephropathy (DN) is one of the most serious chronic complications of diabetes mellitus (DM). Autophagy is an important physiological function for podocytes to maintain stability of intracellular environment. In this study, we planned to clarify the effect of Cordycepin, a traditional Chinese medicine, on DN and the related mechanisms.

Methods

All rats were randomly divided into normal control group, diabetic controls, low-dose group (10 mg/kg), medium-dose group (100 mg/kg), and high-dose group (500 mg/kg). The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein was examined through an automatic biochemistry analyser. Enzyme-linked immunosorbent assay (Elisa) was used to detect the level of IL-1β, IL-6, and IL-18. HE staining was used to examine histopathologic changes. TUNEL staining was used to detected cell apoptosis. The expression of fibrosis markers α-SMA, t-TG, and TIMP-1, apoptosis-related proteins cleaved-caspase3, Bax and Bcl-2, autophagy markers Beclin1, light chain 3 (LC3)I/II, and p62 were evaluated by western blot.

Results

The level of cholesterol, blood sugar, triglyceride, creatinine, and urine protein in the diabetic controls was much higher than that in the normal control group. Obvious histopathology injuries were also found in DN model group. After Cordycepin treatment, all the above indexes were improved compared with the DN group and tissue damages were also alleviated. Further studies showed that Cordycepin suppressed cell apoptosis and renal fibrosis and rescued cell autophagy in DN rat model. Moreover, the results of our in vitro experiments showed that the addition of 3-methyladenine (3-MA, specific autophagy inhibitor) successfully abolished the protective effect of Cordycepin on renal fibrosis through inducing apoptosis and renal fibrosis. The above protective effects of Cordycepin were exhibited in a dose-dependent manner.

Conclusion

Cordycepin participated in the modulation of cell apoptosis, fibrosis, and autophagy induction in DN. Our study for the first time revealed that Cordycepin had a certain therapeutic effect on DN in rats through autophagy induction.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

DN:

Diabetic nephropathy

DM:

Diabetes mellitus

3-MA:

3-Methyladenine

HGF:

Hepatocyte growth factor

T2D:

Type 2 diabetes

TG:

Tripterygium glycoside

STZ:

Streptozotocin

References

  1. Lasaridis AN, Sarafidis PA (2003) Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials? Am J Hypertens 16:689–697

    CAS  Article  Google Scholar 

  2. Kume S, Kitada M, Kanasaki K, Maegawa H, Koya D (2013) Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy. Arch Pharm Res 36:230–236

    CAS  Article  Google Scholar 

  3. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79

    Article  Google Scholar 

  4. Chen J, Zhao D, Zhu M, Zhang M, Hou X, Ding W, Sun S, Bu W, Feng L, Ma S, Jia X (2017) Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. Biomed Pharmacother 89:1362–1369

    CAS  Article  Google Scholar 

  5. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME (2003) The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17:1762–1764

    CAS  Article  Google Scholar 

  6. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820

    CAS  Article  Google Scholar 

  7. Liang S, Jin J, Shen X, Jiang X, Li Y, He Q (2018) Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy. Exp Ther Med 16:2275–2280

    PubMed  PubMed Central  Google Scholar 

  8. Lennon MB, Suhadolnik RJ (1976) Biosynthesis of 3′-deoxyadenosine by Cordyceps militaris. Mechanism of reduction. Biochim Biophys Acta 425:532–536

    CAS  Article  Google Scholar 

  9. Khan MA, Tania M (2018) Cordycepin in anticancer research: molecular mechanism of therapeutic effects. Curr Med Chem 22(3):1021–1027

    Google Scholar 

  10. Li L, He D, Yang J, Wang X (2011) Cordycepin inhibits renal interstitial myofibroblast activation probably by inducing hepatocyte growth factor expression. J Pharmacol Sci 117:286–294

    CAS  Article  Google Scholar 

  11. Ma L, Zhang S, Du M (2015) Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice. Nutr Res 35:431–439

    CAS  Article  Google Scholar 

  12. Yu SH, Dubey NK, Li WS, Liu MC, Chiang HS, Leu SJ, Shieh YH, Tsai FC, Deng WP (2016) Cordyceps militaris treatment preserves renal function in type 2 diabetic nephropathy mice. PLoS One 11:e0166342

    Article  Google Scholar 

  13. Lee J, Cummings BP, Martin E, Sharp JW, Graham JL, Stanhope KL, Havel PJ, Raybould HE (2012) Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 302:R657–R666

    CAS  Article  Google Scholar 

  14. Isobe K, Adachi K, Hayashi S, Ito T, Miyoshi A, Kato A, Suzuki M (2012) Spontaneous glomerular and tubulointerstitial lesions in common marmosets (Callithrix jacchus). Vet Pathol 49:839–845

    CAS  Article  Google Scholar 

  15. Liu WY, Wang ZB, Wang Y, Tong LC, Li Y, Wei X, Luan P, Li L (2015) Increasing the permeability of the blood–brain barrier in three different models in vivo. CNS Neurosci Ther 21:568–574

    CAS  Article  Google Scholar 

  16. Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH (2017) Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2alpha-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin 38:1129–1140

    CAS  Article  Google Scholar 

  17. Geletu AH, Teferra AS, Sisay MM, Teshome DF (2018) Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa. Ethiopia. BMC Res Notes 11:532

    Article  Google Scholar 

  18. Hu P, Chen W, Bao J, Jiang L, Wu L (2014) Cordycepin modulates inflammatory and catabolic gene expression in interleukin-1beta-induced human chondrocytes from advanced-stage osteoarthritis: an in vitro study. Int J Clin Exp Pathol 7:6575–6584

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Liang SM, Lu YJ, Ko BS, Jan YJ, Shyue SK, Yet SF, Liou JY (2017) Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity. Sci Rep 7:43930

    Article  Google Scholar 

  20. Yong T, Chen S, Xie Y, Chen D, Su J, Shuai O, Jiao C, Zuo D (2018) Cordycepin, a characteristic bioactive constituent in Cordyceps militaris, ameliorates hyperuricemia through URAT1 in hyperuricemic mice. Front Microbiol 9:58

    Article  Google Scholar 

  21. Sun T, Dong W, Jiang G, Yang J, Liu J, Zhao L, Ma P (2019) Cordyceps militaris improves chronic kidney disease by affecting TLR4/NF-kappaB redox signaling pathway. Oxid Med Cell Longev 2019:7850863

    PubMed  PubMed Central  Google Scholar 

  22. Hong T, Cui LK, Wen J, Zhang MH, Fan JM (2015) Cordycepin protects podocytes from injury mediated by complements complex C5b-9. Sichuan Da Xue Xue Bao Yi Xue Ban 46(173):178 (227)

    Google Scholar 

  23. Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K (2009) Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9:98–105

    Article  Google Scholar 

  24. Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65:755–767

    CAS  Article  Google Scholar 

  25. Zhang Y, Zhao S, Wu D, Liu X, Shi M, Wang Y, Zhang F, Ding J, Xiao Y (2018) MicroRNA-22 promotes renal tubulointerstitial fibrosis by targeting PTEN and suppressing autophagy in diabetic nephropathy. J Diabetes Res 2018:4728645

    PubMed  PubMed Central  Google Scholar 

  26. Gong J, Jin J, Zhao L, Li Y, Li Y, He Q (2018) Tripterygium glycoside protects against puromycin amino nucleoside induced podocyte injury by upregulating autophagy. Int J Mol Med 42:115–122

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Nephrology, The First Affiliated Hospital of Shenzhen University and Shenzhen Second People’s Hospital, No. 3002 Sungang West Road, Futian District, Shenzhen, Guangdong, 518000, P.R. China

    Tao Cao, Ricong Xu, Yi Xu, Yang Liu, Dongli Qi & Qijun Wan

Authors
  1. Tao Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ricong Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dongli Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qijun Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tao Cao.

Ethics declarations

Conflict of interest

The authors have declared that no competing interest exists.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cao, T., Xu, R., Xu, Y. et al. The protective effect of Cordycepin on diabetic nephropathy through autophagy induction in vivo and in vitro. Int Urol Nephrol 51, 1883–1892 (2019). https://doi.org/10.1007/s11255-019-02241-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02241-y

Keywords

  • Diabetic nephropathy
  • Cordycepin
  • Autophagy
  • Apoptosis